Fuller & Thaler Asset Management Inc. Purchases 59,997 Shares of Globus Medical, Inc. (NYSE:GMED)

Fuller & Thaler Asset Management Inc. grew its position in Globus Medical, Inc. (NYSE:GMED - Free Report) by 9.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 723,401 shares of the medical device company's stock after acquiring an additional 59,997 shares during the period. Fuller & Thaler Asset Management Inc. owned about 0.53% of Globus Medical worth $59,832,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Vanguard Group Inc. raised its position in shares of Globus Medical by 2.3% during the 4th quarter. Vanguard Group Inc. now owns 10,863,834 shares of the medical device company's stock valued at $898,548,000 after buying an additional 240,218 shares during the period. JPMorgan Chase & Co. raised its stake in Globus Medical by 7.7% during the 4th quarter. JPMorgan Chase & Co. now owns 2,804,330 shares of the medical device company's stock valued at $231,946,000 after acquiring an additional 199,556 shares during the last quarter. Geode Capital Management LLC boosted its position in Globus Medical by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 1,897,212 shares of the medical device company's stock worth $156,969,000 after purchasing an additional 12,151 shares in the last quarter. Geneva Capital Management LLC raised its stake in Globus Medical by 13.6% in the 4th quarter. Geneva Capital Management LLC now owns 1,815,837 shares of the medical device company's stock valued at $150,188,000 after purchasing an additional 217,707 shares during the last quarter. Finally, Norges Bank acquired a new position in shares of Globus Medical during the 4th quarter valued at about $117,102,000. Institutional investors and hedge funds own 95.16% of the company's stock.

Globus Medical Trading Up 0.2 %

GMED traded up $0.17 during trading on Tuesday, reaching $72.79. 148,699 shares of the company's stock were exchanged, compared to its average volume of 1,037,109. The firm has a fifty day moving average price of $74.07 and a two-hundred day moving average price of $80.17. Globus Medical, Inc. has a one year low of $49.33 and a one year high of $94.93. The stock has a market capitalization of $10.01 billion, a PE ratio of 97.04, a price-to-earnings-growth ratio of 1.61 and a beta of 1.28.

Globus Medical (NYSE:GMED - Get Free Report) last posted its quarterly earnings data on Thursday, February 20th. The medical device company reported $0.84 EPS for the quarter, beating analysts' consensus estimates of $0.74 by $0.10. Globus Medical had a net margin of 4.09% and a return on equity of 10.83%. The company had revenue of $657.29 million for the quarter, compared to analyst estimates of $646.19 million. Sell-side analysts expect that Globus Medical, Inc. will post 3.44 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have weighed in on GMED. Wells Fargo & Company decreased their price target on Globus Medical from $95.00 to $93.00 and set an "overweight" rating for the company in a report on Friday, February 21st. Truist Financial reduced their price target on shares of Globus Medical from $82.00 to $80.00 and set a "hold" rating for the company in a research note on Friday, April 11th. Needham & Company LLC reissued a "hold" rating on shares of Globus Medical in a research note on Tuesday, March 18th. Canaccord Genuity Group boosted their price target on shares of Globus Medical from $92.00 to $101.00 and gave the company a "buy" rating in a report on Friday, January 10th. Finally, StockNews.com lowered shares of Globus Medical from a "buy" rating to a "hold" rating in a research note on Friday, March 21st. Four investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $96.91.

Globus Medical Profile

Globus Medical, Inc, a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.